FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-7683com.
(The FASEB Journal. 2007;21:2124-2134.)
© 2007 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.06-7683comv1
fj.06-7683comv2
fj.06-7683comv3
21/9/2124    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maillet, E. L.
Right arrow Articles by Galzi, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maillet, E. L.
Right arrow Articles by Galzi, J.-L.

A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties

Emeline L. Maillet*,1,§, Nadia Pellegrini{dagger},§, Celine Valant{dagger},§, Bernard Bucher{ddagger},§, Marcel Hibert{dagger},§, Jean-Jacques Bourguignon{dagger},§ and Jean-Luc Galzi*,§

§ Institut Gilbert-Laustriat, UMR 7175 CNRS/Universite-Strasbourg I, Strasbourg, France;

* Departement Recepteurs et Protéines Membranaires; ESBS, Illkirch, France;

{dagger} Departement de Pharmacologie et Physicochimie des Interactions Cellulaires et Moleculaires and

{ddagger} Departement de Pharmacochimie de la Communication Cellulaire, Faculte de Pharmacie, Illkirch, France

1The Mt. Sinai School of Medicine, Box 1065, Department of Neuroscience, 1425 Madison Ave., New York, NY 10029, USA. E-mail: emeline.maillet{at}mssm.edu

The orthosteric agonist neurokinin A (NKA) interacts with the tachykinin NK2 receptors (NK2Rs) via an apparent sequential binding process, which stabilizes the receptor in at least two different active conformations (A1L and A2L). The A1L conformation exhibits fast NKA dissociation kinetics and triggers intracellular calcium elevation; the A2L conformation exhibits slow NKA dissociation kinetics and triggers cAMP production. The new compound LPI805 is a partial and noncompetitive inhibitor of NKA binding to NK2Rs. Analysis of NKA dissociation in the presence of LPI805 suggests that LPI805 decreases the number of NKA-NK2R complexes in A2L conformation while increasing those in the A1L conformation. Analysis of signaling pathways of NK2Rs shows that LPI805 dramatically inhibits the NKA-induced cAMP response while slightly enhancing the NKA-induced calcium response. Analysis of NKA association kinetics reveals that LPI805 promotes strong and specific destabilization of the NKA-NK2R complexes in the A2L conformation whereas access of NKA to the A1L conformations is unchanged. Thus, to our knowledge, LPI805 is the first example of a conformation-specific allosteric antagonist of a G-protein-coupled receptor. This work establishes the use of allosteric modulators in order to promote functional selectivity on certain agonist-receptor interactions.—Maillet, E. L., Pellegrini, N., Valant, C., Bucher, B., Hibert, M., Bourguignon, J-J., Galzi, J-L. A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties.


Key Words: allosterism • signal transduction • GPCR • neurokinin • drug discovery




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Quiniou, P. Sapieha, I. Lahaie, X. Hou, S. Brault, M. Beauchamp, M. Leduc, L. Rihakova, J.-S. Joyal, S. Nadeau, et al.
Development of a Novel Noncompetitive Antagonist of IL-1 Receptor
J. Immunol., May 15, 2008; 180(10): 6977 - 6987.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Kenakin
Functional Selectivity through Protean and Biased Agonism: Who Steers the Ship?
Mol. Pharmacol., December 1, 2007; 72(6): 1393 - 1401.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. C. Michel and A. E. Alewijnse
Ligand-Directed Signaling: 50 Ways to Find a Lover
Mol. Pharmacol., November 1, 2007; 72(5): 1097 - 1099.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The Federation of American Societies for Experimental Biology.